Ruixuan Luo - Publications, H-index & Citations

Ruixuan Luo

harbour biomed

8H指数

32论文数

1.3K被引数

收录论文 4

发表时间

Safety; Tolerability; and Pharmacokinetics of HBM9378 (SKB378/WIN378); a Fully Human IgG1 Monoclonal Antibody Against TSLP After Single Ascending Doses in Chinese Healthy Subjects 安全性；耐受性；以及HBM9378 (SKB378/WIN378)的药代动力学，HBM9378是一种针对TSLP的全人源IgG1单克隆抗体，在单次递增剂量给药后的中国健康受试者中。

drug design; development and therapy

IF0

2026-03-18

OAAI

Xiaojia Yang; Min Xu; Nan Cao; Shuai Zhao; Yuanqing Wei; Jia Lu; Ruixuan Luo; Junyou Ge; Xiaolu Tao; Wen He

Efficacy and safety of HBM4003 combined with toripalimab in refractory neuroendocrine neoplasms: a multicenter, phase II study HBM4003与toripalimab联合治疗难治性神经内分泌新生物的疗效与安全性：一项多中心、II期研究

eClinicalMedicine

IF10

2025-06-01

OAAI

Panpan Zhang; Kai Chen; Jianwei Yang; Lijie Song; Fei Zheng; Ruixuan Luo; Yebo He; Feng Li; Di Yang; Nan Cao; Xiaolu Tao; Lin Shen; Ming Lu

Toripalimab in combination with HBM4003, an anti-CTLA-4 heavy chain-only antibody, in advanced melanoma and other solid tumors: an open-label phase I trial Toripalimab与HBM4003 (一种anti-CTLA-4的仅重链抗体) 联合治疗晚期黑色素瘤和其他实体瘤: 一项开放标签I期试验

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2024-10-04

OAAI

Tang, Bixia; Chen, Yu; Jiang, Yu; Fang, Meiyu; Gao, Quanli; Ren, Xiubao; Yao, Li; Huang, Gang; Chen, Jing; Zhang, Xiaoshi; Li, Rongqing; Zhao, Shuai; Gao, Meijuan; Luo, Ruixuan; Qi, Meng; Li, Feng; Zheng, Fei; Lee, Michael; Tao, Xiaolu; Duan, Rong; Guo, Jun; Chi, Zhihong; Cui, Chuanliang

Adversarial parameter defense by multi-step risk minimization

NEURAL NETWORKS

IF6.3

2021-12-01

OAAI

Zhang, Zhiyuan; Luo, Ruixuan; Ren, Xuancheng; Su, Qi; Li, Liangyou; Sun, Xu

研究方向